Ticker AKCA – Akcea Therapeutics – sales, description, marketcap – Tickerday.com

AKCA

Akcea Therapeutics

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 1.84B; Volume: 250.75K; AvgVol 3m: 508.74K; Beta: ;

Cost estimate:

P/E: ; EPS: -0.85; EPS growth quarter/prev quarter: -21.00%;

EPS growth this year: 115.80%; EPS growth past 5 years: 19.40%;

EPS ttm: -0.85;

P/S: 5.48; P/B: 2.92; P/Cashflow: 4.73; P/FCF: 19.26;

Sales: 336.55M; Sales growth quarter/prev quarter: -15.80%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 94.90%; Profit Margin: -12.30%; Operating Margin: -13.60%;

ROA – return on assets: -8.00%; ROE – return on equity: -8.90%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 0.40%; Insider Transactions:-2.40%;

Institutional Ownership: 19.80%; Institutional Transactions: -3.84%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *